Oncology Analysis
🇪🇺 EMAExpert commentary and market intelligence for pharma strategy teams
Showing 1–12 of 33 articles
European Cancer Guidelines Add Delcath Liver Therapy for Eye Melanoma
Florian Lordick Elected ESMO President 2029–2030: What Pharma Teams Should Watch
Circulating Biomarkers: Additional Evidence Supporting Their Clinical Use in Breast Cancer
Medscape Education Leverages AI for Hematology at EHA 2026
ASCO26: AstraZeneca's Camizestrant Data Aims to Sway FDA Approval
Medscape's AI Integration in Hematology: A Catalyst for Change at EHA 2026
NICE Technology Appraisals: Impact on Market Access for Novel Oncology Drugs
CAR-T Cell Therapy Europe: Clinical Trials, Safety & Market Access Insights
Antibody-Drug Conjugates in Breast Cancer: Enhertu vs. Trodelvy in EU Market
EMA Conditional Marketing Authorization: Linvoseltamab for RRMM in EU
Bispecific Antibody Approvals in EU: Teclistamab & Elranatamab Review
EMA Conditional Approval Pathway: Insights from Repotrectinib Oncology Approval